This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ruby Chandy Elected To AMETEK Board Of Directors

BERWYN, Pa., May 9, 2013 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced that the Company's stockholders have elected Ruby Chandy to its Board of Directors. Ms. Chandy currently is President of Pall Industrial, a $1.3 billion division of Pall Corporation.

"We are very pleased to welcome Ruby to AMETEK's Board of Directors.  She is an experienced business leader with a strong strategic and marketing background across a number of industrial and technology businesses.  Her contributions to the Company and the Board should significantly benefit the continued growth of AMETEK," commented Frank S. Hermance, AMETEK Chairman and Chief Executive Officer.

Ms. Chandy has extensive experience in general management, marketing and strategy. She joined Pall Corporation in her current position in 2012 and is a member of its Executive Management Team.  She also has held leadership positions at Dow Chemical Company, Thermo Fisher Scientific, Boston Scientific, Millipore Corporation and McKinsey & Co.

Prior to joining Pall, Ms. Chandy most recently led the Dow Plastics Additives Business and served as Chief Marketing Officer for Dow Chemical.  In her general management and marketing roles, Ms. Chandy has specialized in driving growth through global strategy deployment, new product innovation, business development and market expansion.

Ms. Chandy is a graduate of the Massachusetts Institute of Technology, where she earned a Bachelor's Degree in Materials Science and Engineering and a Master's Degree in Business.  She also holds a Master's Degree in Materials Science and Engineering from Northwestern University

Corporate Profile AMETEK is a leading global manufacturer of electronic instruments and electro-mechanical devices with annualized sales of $3.5 billion.  AMETEK's Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions, Global & Market Expansion and New Products.  AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital.  The common stock of AMETEK is a component of the S&P MidCap 400 and the Russell 1000 Indices.

Forward-looking Information Statements in this news release relating to future events, such as AMETEK's expected business and financial performance are "forward-looking statements."  Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include AMETEK's ability to consummate and successfully integrate future acquisitions; risks associated with international sales and operations; AMETEK's ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve.  A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K.  AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

Contact: Kevin C. Coleman (610) 889-5247

SOURCE AMETEK, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs